Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitro diagnostics. Our goal is to revolutionize the diagnostics market by personalizing and decentralizing current diagnostic solutions, enabling rapid diagnosis and improving patient prognosis. We achieve this by offering cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (lVD) solutions that are rapid, accessible, and affordable on a global scale.

Since its establishment, Anbio has been committed to delivering the most advanced diagnostic solutions while ensuring cost-effectiveness for our customers. Our extensive capabilities in research and development, manufacturing, and global product distribution logistics allowing us to continuously focus on cost reduction while offering a wide range of mature laboratory diagnostics and point-of-care technology (POCT) products. Our product range spans across cancer, cardiovascular
conditions, pharmacogenomics, hormones, infectious diseases, inflammation, and drugs of abuse tests.